Servier Pharmaceuticals is a commercial-stage pharmaceuticals company with a passion for innovation and improving the lives of patients, their families and caregivers. In the United States, Servier Pharmaceuticals is committed to building a robust portfolio, starting with oncology, with future growth driven by innovation in other areas of unmet medical need, leveraging Servier’s global portfolio and seeking acquisitions, licensing deals and partnerships.
Servier Pharmaceuticals believes co-creation is fundamental to driving innovation and is actively building alliances that bring solutions to patients’ lives and can accelerate access to therapies. We are building relationships with academia, venture capitalists, biotech and pharmaceutical peers and advocates with the aim of entering into mutually beneficial and complementary partnerships where each organization’s skill sets are recognized and leveraged for the benefit of patients.
With our commercial and scientific expertise, global reach and commitment to clinical excellence, Servier Pharmaceuticals is dedicated to bringing the promise of tomorrow to the patients that we serve.
To learn more, click here: https://www.oncaspar.com/
Below website link: Please see Full Prescribing Information
To learn more here, click here: https://www.tibsovopro.com/
Please see Full Prescribing Information, including Boxed WARNING, for TIBSOVO (ivosidenib tablets).
Patient Assistance Programs
At Servier Pharmaceuticals we know that navigating details of the financial and personal assistance needed for treating your diagnosis can be overwhelming. That’s why we have it all here in one place so you can easily find the information, direction, and resources to help you, your family, and caregivers throughout your journey.
To learn more, click here – https://servierone.com/s/patient